Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

NCT02549339 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT02549339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02549339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
November 13, 2015
Completion date
August 10, 2017
Enrollment
383 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis